Assay Details
Target Gene Details
Entrez Gene ID: | 7991 |
Gene Name: | tumor suppressor candidate 3 |
Gene Aliases: |
D8S1992, M33, MRT22, MRT7, N33, OST3A |
Location: |
Chr.8:15540087-15766649 on Build GRCh38 |
Assay Gene Location: | Within Intron 1 |
| Gene Symbol | Transcript Accession | Exon Location | Assay Transcript Location | Protein ID |
|---|---|---|---|---|
| TUSC3 | NM_006765.3 | NP_006756.2 | ||
| NM_178234.2 | NP_839952.1 | |||
| BC010370.1 | AAH10370.1 | |||
| BT020002.1 | AAV38805.1 | |||
| DA796279.1 | ||||
| U42349.1 | AAB18374.1 |
Target Copy Number Variation Details
DGV Version: |
Release date: 2016-05-15, GRCh GRCh38 |
| Target Variation |
Location | CNV Subtype |
Genes |
|---|---|---|---|
| nsv1161734 | Chr.8:15533647 - 15548772 on Build GRCh38 | Deletion |
|
| esv3572557 | Chr.8:15469077 - 15543402 on Build GRCh38 | Loss |
|
| nsv437055 | Chr.8:15398926 - 15806828 on Build GRCh38 | Loss |
|
| nsv6089 | Chr.8:15538984 - 15565828 on Build GRCh38 | Deletion |
|
| esv2759598 | Chr.8:14768691 - 15907197 on Build GRCh38 | Loss |
|
| esv3616403 | Chr.8:15528780 - 15600263 on Build GRCh38 | Loss |
|
| dgv248e55 | Chr.8:14773418 - 15806518 on Build GRCh38 | Loss |
|
| nsv517314 | Chr.8:15531057 - 15554099 on Build GRCh38 | Loss |
|
| nsv610466 | Chr.8:14469128 - 15809390 on Build GRCh38 | Loss |
|
| nsv818605 | Chr.8:14773392 - 15802730 on Build GRCh38 | Loss |
|
| nsv610524 | Chr.8:15419198 - 15568674 on Build GRCh38 | Loss |
|
| nsv1029399 | Chr.8:14978756 - 16296799 on Build GRCh38 | Gain |
|
| nsv8298 | Chr.8:14772387 - 15806223 on Build GRCh38 | Gain+Loss |
|
| nsv1020054 | Chr.8:15444894 - 15812092 on Build GRCh38 | Gain |
|
| nsv465554 | Chr.8:15537635 - 15554099 on Build GRCh38 | Loss |
|
More Information
Additional Information:
For this assay, SNP(s) [rs112256089] are located under a primer or probe sequence. To help evaluate the possible impact of a given SNP on your experiment, please refer to the 1000 Genomes and NCBI dbSNP databases. A higher minor allele frequency in your study population represents a higher risk to assay performance.
Set Membership: |
|

Genomic Map